课题基金 / 基金详情

Inhibiting Interleukin-1 receptor during pregnancy to prevent neonatal mortality and morbidity induced by placental/chorioamniotic inflammation

Inhibiting Interleukin-1 receptor during pregnancy to prevent neonatal mortality and morbidity induced by placental/chorioamniotic inflammation
妊娠期间抑制白介素 1 受体可预防胎盘/绒毛膜羊膜炎症引起的新生儿死亡和发病
批准号：
339562
负责人：
Nadeau-Valle Mathieu
金额：
$10.93万
依托单位：
Universit de Montral
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2015
资助国家：
加拿大
项目状态：
已结题
起止时间：
2015-11-01 至 2018-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=339562&lang=en
关键词：
Allosteric Modulator Chorioamnionitis Fetal Brain Immunity Inflammation Interleukin-1 Neonatal Morbidity Pregnancy Outcomes Preterm Birth Preterm Labor

项目摘要

项目成果

Nadeau-Valle Mathieu的其他基金

相似基金

相关文献

中文摘要
翻译
子宫内的炎症是包括早产在内的大多数妊娠并发症的原因。早产是新生儿死亡和发病的主要原因，并与许多新生儿疾病有关，这些疾病使婴儿
英文摘要
Inflammation inside the uterus is responsible for most of pregnancy complications, including preterm birth. Preterm birth is the leading cause of neonatal mortality and morbidity, and is associated with many diseases of the newborn which subject the infan
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inhibiting Interleukin-1 receptor during pregnancy to prevent neonatal mortality and morbidity induced by placental/chorioamniotic inflammation
Characterisation of a Small Non-Competitive Peptide Inhibitor of IL-1RI in Preterm Labor
  • 批准号：
    331286
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2014
  • 负责人：
    Nadeau-Valle Mathieu
  • 依托单位：
    Universit de Montral
海外基金